xanomeline has been researched along with phorbols in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bymaster, FP; DeLapp, NW; Eckols, K; Mitch, CH; Shannon, HE; Ward, JS | 1 |
1 other study(ies) available for xanomeline and phorbols
| Article | Year |
|---|---|
The muscarinic M1 agonist xanomeline increases soluble amyloid precursor protein release from Chinese hamster ovary-m1 cells.
Topics: Amyloid beta-Protein Precursor; Animals; Carbachol; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Electrophoresis; Humans; Immunoblotting; Muscarinic Agonists; Phorbols; Pyridines; Thiadiazoles | 1995 |